2015 VAM: 3101 - Urticaria: A Non-Allergic Disorder Treated as an Allergic Disorder

This recording addresses the conflicting evidence for the diagnosis and management of urticaria. These guidelines suggest that urticaria is not an allergic disease and that tests for allergy should not be performed. Instead they suggest that urticaria is an autoimmune disease although few tests for autoimmunity should be performed. This leaves the allergist without much ammunition for either diagnosis or management although omalizumab was recently approved as a treatment for urticaria. The recording explores these issues and how these conflicting pieces of evidence relate to each other.

AMA PRA Category 1 Credits™: 1.50
CE: 1.50

Credit must be claimed by June 30, 2017.  Any credit request on or after July 1, 2017 will be subject to an administrative fee.

System requirements: Two most recent versions of Internet Explorer, Safari, Google Chrome, and Firefox

Target Audience

Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals

Learning Objectives

Upon completion of this activity, participants will be able to:
1. Discuss the urticaria guidelines
2. Identify and utilize the treatments appropriately, including anti-IgE
3. Identify the mechanisms of urticaria

Summary
Available credit: 
  • 1.50 Attendance
    Attendance credit.
  • 1.50 CE
    CE credit.
  • 1.50 CME
    CME credit.
Course opens: 
08/23/2015
Course expires: 
06/30/2017
Cost:
$15.00

Dr. Stephen C. Dreskin, MD PhD FAAAAI, University of Colorado Denver

Dr. Sarbjit S. Saini, MD FAAAAI, Department of Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD

Prof. Marcus Maurer, MD, Department of Dermatology and Allergy, Charité – Universitätsmedizin, Berlin, Germany

Available Credit

  • 1.50 Attendance
    Attendance credit.
  • 1.50 CE
    CE credit.
  • 1.50 CME
    CME credit.

Price

Cost:
$15.00
Please login or register to take this course.